MedTrace Logo

Dapagliflozin Post Marketing Surveillance in HF and CKD

NCT05134701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 815

Last updated 2025-01-13

No results posted yet for this study

Summary

This is an observational, non-interventional, single-arm multicenter study. The objectives of this study are to assess safety and effectiveness of Forxiga in a real world setting in patients who are prescribed with the study drug according to the newly approved indications in the Republic of Korea

Conditions

Sponsors & Collaborators

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-10
Primary Completion
2024-05-20
Completion
2024-05-20

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05134701 on ClinicalTrials.gov